risks with glp 1 GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Study: GLP-1s 'hold promise' for
Description
This helps with counseling and risk assessment
2009;21:978-e78
Research suggests weight regain is common when GLP-1 medications are discontinued
Major players like Novo Nordisk, Eli Lilly, and AstraZeneca are making strategic investments
Strong track record : Thousands of patients have left positive reviews praising their weight loss results and the support they received
For women navigating perimenopause or menopause, weight loss should be approached with muscle, bones, sleep, mood, hot flushes, digestion and recovery in mind
